UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, DC 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the

Securities Exchange Act of 1934

Date of report (Date of earliest event reported): January 27, 2009

MEDICAL SOLUTIONS MANAGEMENT INC.

(Exact name of registrant as specified in its charter)

Nevada

000-13858

86-0214815

(State or other jurisdiction

of incorporation)

(Commission File Number)

(I.R.S. Employer

Identification No.)

3030 Horseshoe Drive South, Suite 200

Naples, Florida 34101

(Address of principal executive offices) (Zip Code)

(508) 597-6300

(Registrant’s telephone number, including area code)

(Former name or former address, if changed since last report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

¨	Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

¨	Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

¨	Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

¨	Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Item 5.02.

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

On January 27, 2009, Lowell Fisher resigned as President and Interim Chief Executive Officer of Medical Solutions Management Inc. (the “Registrant”), stating as reasons Mr. Fisher’s wife’s recent death and his “awareness of an ongoing federal investigation that involves MSMT.” The Registrant has to date had no opportunity to investigate the underlying substance or circumstances of the investigation.

On January 28, 2009, Shad Stastney resigned from the Board of Directors of the Registrant effective immediately.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

Date: February 2, 2009


MEDICAL SOLUTIONS MANAGEMENT INC.

By:		/s/ Marshall Sterman
Name:		Marshall Sterman
Title:		Chairman of the Board of Directors

MEDICAL SOLUTIONS MANAGEMENT INC. 8-K